BRCA1/2 mutations and outcomes among Middle Eastern patients with early-onset breast cancer in Oman.
Waleed S Al AmriAhmed H Al AmriAisha Al AbriThomas A HughesFatma Al LawatiPublished in: The oncologist (2024)
Our findings showed that germline BRCA1/2 mutations were not over-represented in EOBC cases in Oman, and therefore are unlikely to be responsible for high EOBC rates.